BRINAVESS™ For Infusion Approved In The European Union For Rapid Conversion Of Recent Onset Atrial Fibrillation

JapanHerald.com		Wednesday 8th February 2012	Issue 2012/0208
			Follow us on

	More Breaking Health News
	Nazi medical tools to be auctioned
	President of Maldives quits after weeks of protests
	Myanmar reforms leads to US partially lifting embargo
	Philippines earthquake toll 48, scores missing
	Russian foreign minister in Syria, violence escalates
	JAL says first Dreamliner delivery will be delayed
	As Greece mulls a proposed crunch, unions strike in protest
	Glencore, Xstrata sign giant $90 bn merger


Get Breaking Health News headlines emailed to you daily.

BRINAVESS™ For Infusion Approved In The European Union For Rapid Conversion Of Recent Onset Atrial Fibrillation
Source: Medical News Today
Friday 3rd September, 2010

MSD (known in the US and Canada as Merck) (NYSE:MRK) and Cardiome Pharma Corp.

(NASDAQ: CRME/ TSX: COM) announced that the intravenous (IV) formulation of BRINAVESS™ (vernakalant) has been grant... ...

Read the full story at Medical News Today

Share this page

Email this story to a friend

Have your say on this story